GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 443.99M | 432.21M | 416.67M | 393.58M | 357.47M |
| Total Other Revenue | 10.43M | 10.47M | 10.87M | 8.61M | 4.85M |
| Total Revenue | 454.43M | 442.68M | 427.54M | 402.19M | 362.32M |
| Cost of Revenue | 139.13M | 134.77M | 129.36M | 122.08M | 118.90M |
| Gross Profit | 315.30M | 307.91M | 298.18M | 280.11M | 243.42M |
| SG&A Expenses | 291.14M | 261.97M | 237.82M | 211.07M | 187.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 514.10M | 475.98M | 439.21M | 392.23M | 356.88M |
| Operating Income | -59.67M | -33.31M | -11.67M | 9.96M | 5.44M |
| Income Before Tax | -106.30M | -77.47M | -21.14M | 2.51M | 1.54M |
| Income Tax Expenses | 62.00K | 334.00K | -116.00K | 424.00K | 130.00K |
| Earnings from Continuing Operations | -106.36 | -77.81 | -21.02 | 2.08 | 1.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.36M | -77.81M | -21.02M | 2.08M | 1.41M |
| EBIT | -59.67M | -33.31M | -11.67M | 9.96M | 5.44M |
| EBITDA | -33.70M | -7.85M | 12.65M | 32.97M | 27.90M |
| EPS Basic | -3.63 | -2.65 | -0.73 | 0.08 | 0.04 |
| Normalized Basic EPS | -1.35 | -0.74 | -0.35 | 0.40 | 0.31 |
| EPS Diluted | -3.63 | -2.67 | -0.75 | 0.06 | 0.02 |
| Normalized Diluted EPS | -1.35 | -0.75 | -0.36 | 0.39 | 0.30 |
| Average Basic Shares Outstanding | 116.89M | 115.76M | 114.58M | 113.31M | 111.61M |
| Average Diluted Shares Outstanding | 116.89M | 116.94M | 115.75M | 114.48M | 112.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |